Importance of tricuspid regurgitation velocity threshold in risk assessment of pulmonary hypertension-long-term outcome of patients submitted to aortic valve replacement
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author García-Ribas, Cora
- dc.contributor.author Ble, Mireia
- dc.contributor.author Gómez Pérez, Miguel Angel
- dc.contributor.author Mas Stachurska, Aleksandra
- dc.contributor.author Farré López, Núria
- dc.contributor.author Cladellas Capdevila, M.Mercedes
- dc.date.accessioned 2022-07-28T07:11:27Z
- dc.date.available 2022-07-28T07:11:27Z
- dc.date.issued 2021
- dc.description.abstract Background: the upper physiological threshold for tricuspid regurgitation velocity (TRV) of 2.8 m/s proposed by the Pulmonary Hypertension (PH) guidelines had been questioned. The aim of this study was to evaluate the prognostic significance of preoperative PH in patients with aortic stenosis, long-term after valve replacement, using two different TRV thresholds (2.55 and 2.8 m/s). Methods: four hundred and forty four patients were included (mean age 73 ± 9 years; 55% male), with a median follow-up of 5.8 years (98% completed). Patients were divided into three PH probability groups according to guidelines (low, intermediate and high) for both thresholds (TRV ≤ 2.8 m/s and TRV ≤ 2.55 m/s), using right atrial area>18 cm2 and right ventricle/left ventricle ratio>1 as additional echocardiographic variables. Results: in patients with measurable TRV (n = 304), the low group mortality rate was 25% and 30%, respectively for 2.55 and 2.8 m/s TRV thresholds. The intermediate group with TRV > 2.55 m/s was an independent mortality risk factor (HR 2.04; 95% CI: 1.91 to 3.48, p = 0.01), in contrast to the intermediate group with TRV>2.8 m/s (HR 1.44; 95% CI: 0.89 to 2.32, p = 0.14). Both high probability groups were associated with an increased mortality risk, as compared to their respective low groups. When including all patients (with measurable and non-measurable TRV), both intermediate groups remained independently associated with an increased mortality risk: HR 1.62 (95% CI 1.11 to 2.35 p = 0.01) for the new cut-off point; and HR 1.43 (95% CI: 0.96 to 2.13, p = 0.07) for guidelines threshold. Conclusion: A TRV threshold of 2.55 m/s, together with right cavities measures, allowed a better risk assessment of patients with PH secondary to severe aortic stenosis, with or without tricuspid regurgitation.
- dc.format.mimetype application/pdf
- dc.identifier.citation Garcia-Ribas C, Ble M, Gómez M, Mas-Stachurska A, Farré-López N, Cladellas M. Importance of tricuspid regurgitation velocity threshold in risk assessment of pulmonary hypertension-long-term outcome of patients submitted to aortic valve replacement. Front Cardiovasc Med. 2021 Nov 10; 8: 720643. DOI: 10.3389/fcvm.2021.720643
- dc.identifier.doi http://dx.doi.org/10.3389/fcvm.2021.720643
- dc.identifier.issn 2297-055X
- dc.identifier.uri http://hdl.handle.net/10230/53869
- dc.language.iso eng
- dc.publisher Frontiers
- dc.rights Copyright © 2021 Garcia-Ribas, Ble, Gómez, Mas-Stachurska, Farré-López and Cladellas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) http://creativecommons.org/licenses/by/4.0/. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Aortic stenosis (AS)
- dc.subject.keyword Echocardiography
- dc.subject.keyword Left heart valve disease
- dc.subject.keyword Pulmonary hypertension
- dc.subject.keyword Tricuspid regurgitation threshold
- dc.title Importance of tricuspid regurgitation velocity threshold in risk assessment of pulmonary hypertension-long-term outcome of patients submitted to aortic valve replacement
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion